American Society of Clinical Oncology (ASCO)

June 1-5, 2018- Chicago, IL


Research

Contact an Author

Scientific Posters

Poster # 1524

Monday, June 4, 2018 1:15 - 4:45pm

Sarah Lee, Melissa Frey, Arthur Dean, Zachary Schwartz, Jessica Martineau, Kathleen Lutz, Erin Reese, Emily Dalton, Annie Olsen, Bhavana Pothuri, Leslie Boyd, John Curtin, Stephanie Blank. Facilitated referral pathway for genetic testing at the time of ovarian cancer diagnosis: uptake of genetic assessment and testing and impact on patient-reported stress, anxiety and depression.

Poster # 5579

Monday, June 4, 2018 1:15 - 4:45pm

Daniel Chen, Patrick Reineke, Negar Ghahramani, Ashley Deckman, Erica Wellington, Monalyn Umali-Salvador, Lucia Guidugli, Melissa Pronold, Holly LaDuca, Michelle Jackson. Paired Somatic and Germline Genetic Testing for Ovarian Cancer Patients: Observations, Benefits and Implications for Treatment.

Poster # Online Publications

Friday, June 1, 2018 12:00 - 12:00am

Anton Safonov, Virginia Speare, Jill Dolinsky, Amal Yussuf, Chia-Ling Gau, Katherine Nathanson. Clinical and molecular characteristics of NF1 mutations identified on hereditary cancer multi-gene panels.

Poster # Online Publication

Friday, June 1, 2018 12:00 - 12:00am

Alexandria Meyer, Holly LaDuca, Patrick Reineke, Virginia Speare. Increased Detection of Germline Cancer Susceptibility Mutations Subsequent to Tumor Profiling.

Poster # 1524

Saturday, June 2, 2018 1:15 - 4:45pm

Fergus J. Couch, Hermela Shimelis, Jill Dolinsky, Eric C. Polley, Carrie Horton, Amal Yussuf, Lily Hoang, Jenna Lilyquist, Virginia Speare, Chunling Hu, Steven N. Hart, Holly LaDuca. Expanding BRCA1/2 testing criteria to include other confirmed breast and ovarian cancer susceptibility genes.

Oral Presentations

Session # 1508

Sunday, June 3, 2018 8:00 - 11:00am

Mary Helen Black, Shuwei Li, Holly LaDuca, Jeffery Checn, Robert Hoiness, Stephanie Gutierrez, Hsiao-Mei Lu, Jill S Dolinsky, Jianfeng Xu, Celine Vachon, Fergus J. Couch, Brigette Tippin Davis. Polygenic Risk Score for Breast Cancer in High-Risk Women

Our Blog

Read our blog on why Ambry is using evidence-based quality testing.

Read

Get in Touch With Us

Contact a Sales Rep

Search Results

Start your search...